Utility of cardiac magnetic resonance in assessing right-sided heart failure in sarcoidosis

BMC Medical Imaging

Volumn 13, Issue 1, 2013, Pages

  Lønborg, Jacob ^a,b   Ward, Michael ^a,c   Gill, Anthony ^c   Grieve, Stuart M ^a,d   Figtree, Gemma A ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Rigshospitalet   (Denmark)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Cardiac magnetic resonance; Cardiomyopathy; Heart failure; Myocardial sarcoidosis

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; HEART RIGHT VENTRICLE FUNCTION; HUMAN; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SARCOIDOSIS;

ADULT; CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; SARCOIDOSIS, PULMONARY; VENTRICULAR DYSFUNCTION, RIGHT;

MLCS; MLOWN;

EID: 84872126608     PISSN: None     EISSN: 14712342     Source Type: Journal    
DOI: 10.1186/1471-2342-13-2     Document Type: Article

References (9)

1. Dubrey SW, Falk RH. Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis 2010, 52:336-346. 10.1016/j.pcad.2009.11.010, 20109603.
2. Kim JS, Judson MA, Donnino R, Gold M, Cooper LT, Prystowsky EN, Prystowsky S. Cardiac sarcoidosis. Am Heart J 2009, 157:9-21. 10.1016/j.ahj.2008.09.009, 19081391.
3. Roberts WC, McAllister HA, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977, 63:86-108. 10.1016/0002-9343(77)90121-8, 327806.
4. Soejima K, Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 2009, 20:578-583. 10.1111/j.1540-8167.2008.01417.x, 19175448.
5. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM, Kim RJ. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009, 120:1969-1977. 10.1161/CIRCULATIONAHA.109.851352, 2778859, 19884472.
6. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, Crijns HJ. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005, 45:1683-1690. 10.1016/j.jacc.2005.01.047, 15893188.
7. Figtree GA, Lonborg J, Grieve SM, Ward MR, Bhindi R. Cardiac magnetic resonance imaging for the interventional cardiologist. JACC Cardiovasc Interv 2011, 4:137-148. 10.1016/j.jcin.2010.09.026, 21349451.
8. White SK, Sado DM, Flett AS, Moon JC. Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging. Heart 2012, 98:773-779. 10.1136/heartjnl-2011-301515, 22422587.
9. Azuma A, Kim HW, Parker M, Kim RJ. Prognostic value of delayed enhancement cardiovascular magnetic resonance in patients with sarcoidosis. J Cardiovasc Magn Reson 2012, 14(Suppl 1):O13.